Details

Temeljni instrumentarij določanja in odločanja o (človekovih) pravicah v zvezi z novimi tehnologijami
ID Zalar, Boštjan (Author)

URLURL - Presentation file, Visit http://dk.fdv.uni-lj.si/dr/dr40Zalar.PDF This link opens in a new window

Language:Slovenian
Keywords:genetski inženiring, kloniranje, informiranje, nadzor, diskriminacija, kakovost življenja
Work type:Not categorized
Typology:1.01 - Original Scientific Article
Organization:FDV - Faculty of Social Sciences
Year:2002
Number of pages:Str. 135-154
Numbering:Letn. 18, št. 40
PID:20.500.12556/RUL-5834 This link opens in a new window
UDC:342.7
ISSN on article:0352-3608
COBISS.SI-ID:21683037 This link opens in a new window
Publication date in RUL:11.07.2014
Views:1916
Downloads:273
Metadata:XML DC-XML DC-RDF
:
ZALAR, Boštjan, 2002, Temeljni instrumentarij določanja in odločanja o (človekovih) pravicah v zvezi z novimi tehnologijami. Družboslovne razprave [online]. 2002. Vol. 18, no. 40, p. 135–154. [Accessed 14 April 2025]. Retrieved from: http://dk.fdv.uni-lj.si/dr/dr40Zalar.PDF
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Družboslovne razprave
Shortened title:Družbosl. razpr.
Publisher:Slovensko sociološko društvo, Fakulteta za družbene vede
ISSN:0352-3608
COBISS.SI-ID:7530242 This link opens in a new window

Secondary language

Language:English
Keywords:genetic engineering, cloning, informing, supervision, discrimination, quality of life

Similar documents

Similar works from RUL:
  1. 4-phenethyl-1-propargylpiperidine-derived dual inhibitors of butyrylcholinesterase and monoamine oxidase B
  2. Synthesis of butyrylcholinesterase inhibitors
  3. Design, synthesis and evaluation of novel N-benzylpiperidines as cholinesterase inhibitors
  4. Design and synthesis of tryptophan-based butyrylcholinesterase inhibitors
  5. Cell models for Alzheimer’s and Parkinson’s disease
Similar works from other Slovenian collections:
  1. Alzheimer's disease: confrontation family members with the disease
  2. Health education for familiy members of Alzheimer's disease patients

Back